14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.04 $1.56 Friday, 3rd May 2024 LCTX stock ended at $1.06. This is 0.95% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.67% from a day low at $1.05 to a day high of $1.12.
90 days $0.99 $1.61
52 weeks $0.84 $1.61

Historical Lineage Cell Therapeutics, Inc. prices

Date Open High Low Close Volume
May 03, 2024 $1.09 $1.12 $1.05 $1.06 602 177
May 02, 2024 $1.12 $1.12 $1.04 $1.05 1 815 265
May 01, 2024 $1.11 $1.13 $1.09 $1.13 557 569
Apr 30, 2024 $1.12 $1.15 $1.09 $1.09 764 016
Apr 29, 2024 $1.14 $1.17 $1.12 $1.12 408 170
Apr 26, 2024 $1.11 $1.14 $1.11 $1.14 306 546
Apr 25, 2024 $1.10 $1.14 $1.10 $1.11 330 657
Apr 24, 2024 $1.15 $1.15 $1.10 $1.10 739 011
Apr 23, 2024 $1.13 $1.19 $1.13 $1.14 333 217
Apr 22, 2024 $1.14 $1.17 $1.12 $1.14 400 970
Apr 19, 2024 $1.22 $1.23 $1.12 $1.15 1 089 817
Apr 18, 2024 $1.30 $1.30 $1.18 $1.20 1 027 437
Apr 17, 2024 $1.16 $1.32 $1.16 $1.29 2 305 202
Apr 16, 2024 $1.24 $1.27 $1.15 $1.15 758 764
Apr 15, 2024 $1.31 $1.33 $1.22 $1.25 658 153
Apr 12, 2024 $1.41 $1.43 $1.29 $1.30 1 029 147
Apr 11, 2024 $1.38 $1.45 $1.33 $1.41 828 254
Apr 10, 2024 $1.35 $1.41 $1.33 $1.35 530 217
Apr 09, 2024 $1.47 $1.47 $1.34 $1.40 712 704
Apr 08, 2024 $1.42 $1.47 $1.41 $1.47 927 122
Apr 05, 2024 $1.46 $1.47 $1.38 $1.40 1 199 247
Apr 04, 2024 $1.38 $1.56 $1.38 $1.45 1 879 707
Apr 03, 2024 $1.40 $1.41 $1.32 $1.36 894 589
Apr 02, 2024 $1.42 $1.44 $1.37 $1.40 743 332
Apr 01, 2024 $1.49 $1.52 $1.37 $1.46 2 059 615
Click to get the best stock tips daily for free!

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics. Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa mul... LCTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT